Advarra, a regulatory review solutions and clinical research technology, has unveiled its Study Collaboration solution designed to accelerate study startup by automating workflows, improving real-time visibility, and fostering seamless collaboration and engagement among research stakeholders.

The new offering combines the Longboat technology acquired by Advarra in 2020, which now has over 225,000 users, with Advarra’s study startup delivery program and industry-adopted single sign-on capabilities. The Advarra Study Collaboration solution is provided by clinical trial sponsors and CROs to research sites to enable seamless collaboration on critical processes such as feasibility assessments, document exchange, site training, milestone tracking, and enrollment planning to shorten the time from site selection to recruitment.

The solution includes two products, Advarra Study Startup (SSU) and Advarra Enroll, which work seamlessly together to guide study teams through the site activation process and improve enrollment planning and tracking during study startup and throughout trial conduct. The solution is supported by a multi-year technology investment aimed at further improving site activation speed and compliance.

“Study startup remains one of the most challenging aspects of clinical trials, and it takes time to progress through every milestone—from site identification and feasibility to ethics reviews, contract negotiations, and site training,” said Ashley Davidson, vice president, product lead–sponsor tech strategy at Advarra. “Manual information exchange and disconnected systems often hinder coordination and visibility, creating delays that can cascade through the clinical trial timeline. Addressing these inefficiencies is critical to achieving enrollment goals, especially when 80% of trials fail to enroll patients on time.”

Davidson continued: “Our Study Collaboration solution represents a natural progression for Advarra, building on our role as a trusted partner to over 50,000 monthly research site users of our clinical trial management technology across more than 17,000 facilities. By automating workflows and integrating site activation processes such as regulatory submissions, document management, and training, we’re reducing redundancies and saving valuable time. These enhancements strengthen collaboration between stakeholders, improve compliance, and accelerate research timelines, ultimately helping to bring new treatments to patients faster.”

Advarra Study Collaboration sets teams up for success by providing a centralized, real-time view of activation and enrollment progress across all sites. The solution uniquely allows sites and sponsors to access the entire startup workflow using their own credentials, reducing administrative burden and improving engagement.